8-K: Reborn Coffee Addresses Nasdaq Compliance, Reshuffles Board
Corporate Governance Update
Reborn Coffee, Inc. announced it received a Nasdaq non-compliance notice but has since remedied the issues by appointing two new independent directors and reducing its board size.
Summary
- Reborn Coffee, Inc. received a notification from Nasdaq on February 19, 2026, regarding non-compliance with independent director, audit committee, and compensation committee requirements (Nasdaq Listing Rule 5605).
- Nasdaq provided a cure period until the earlier of the next annual stockholders meeting or February 13, 2027, or by August 12, 2026, if the annual meeting is held before that date.
- The company stated it has remedied all deficiencies under Nasdaq Listing Rule 5605 through new appointments.
- On February 20, 2026, the Board of Directors decreased its size from seven to six members following the resignations of Andy Nasim, Alex Go, and Mi Young Jeong.
- Charles C. Jeong and Mi Jeong Lee were appointed to the Board on February 20, 2026, and are deemed independent under Nasdaq standards.
- Mr. Jeong will chair the Compensation Committee, and Ms. Lee will serve on the Audit Committee.
- Neither new director will be compensated for their Board service.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While the initial non-compliance is negative, the company's swift and effective remediation by appointing independent directors and adjusting board structure is a positive and expected response, mitigating immediate delisting risk.
Positives
- The company has already remedied the Nasdaq non-compliance issues by appointing new independent directors.
- The new directors, Charles C. Jeong and Mi Jeong Lee, are deemed independent under Nasdaq standards.
- The appointments ensure compliance with audit and compensation committee requirements.
- The new directors will not be compensated for their board service, potentially reducing governance costs.
Negatives
- The company initially failed to comply with Nasdaq's independent director, audit committee, and compensation committee requirements.
- Three directors (Andy Nasim, Alex Go, and Mi Young Jeong) resigned from the Board.
Risks
- There is no assurance that the company will meet Nasdaq compliance standards.
- Nasdaq may not grant the company any relief from delisting if compliance is not maintained.
- The company may not ultimately meet applicable Nasdaq requirements for any such relief.
- General risks described in the company's Annual Report on Form 10-K for the year ended December 31, 2024, and its other SEC filings.
Future Outlook
The company's forward-looking statements indicate that while it believes it has remedied the Nasdaq compliance issues, there is no assurance that it will ultimately meet Nasdaq compliance standards or that Nasdaq will grant any necessary relief from delisting.
Management Comments
- The Company, by appointing Charles C. Jeong and Mi Jeong Lee as further described in Item 5.02 below, has remedied all deficiencies under Nasdaq Listing Rule 5605.
Industry Context
StockSavvy.ai notes that maintaining Nasdaq listing compliance is crucial for public companies to ensure liquidity and investor confidence. Non-compliance issues, particularly related to corporate governance, can signal underlying operational or oversight weaknesses, even if quickly remedied. The swift action by Reborn Coffee to address the deficiencies is a positive step, but the initial lapse highlights the ongoing scrutiny public companies face regarding governance structures.
Comparison to Industry Standards
- Maintaining a majority of independent directors and fully independent audit and compensation committees are standard corporate governance best practices for publicly traded companies, particularly those listed on major exchanges like Nasdaq. Companies such as Starbucks (SBUX) and Dutch Bros Inc. (BROS) consistently adhere to these standards to ensure robust oversight and investor protection.
- The initial non-compliance by Reborn Coffee falls short of these industry benchmarks, though the immediate corrective action aligns with the expected response from a company seeking to maintain its listing.
- The appointment of uncompensated independent directors is a common practice, especially for smaller companies, to manage costs while fulfilling governance requirements.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Andy Nasim | N/A | 2026-02-20 | Resignation |
| Director | Alex Go | N/A | 2026-02-20 | Resignation |
| Director | Mi Young Jeong | N/A | 2026-02-20 | Resignation |
| Director | N/A | Charles C. Jeong | 2026-02-20 | Appointment to fill vacancy and address Nasdaq compliance |
| Director | N/A | Mi Jeong Lee | 2026-02-20 | Appointment to fill vacancy and address Nasdaq compliance |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Size Reduction | The Board of Directors resolved to decrease the size of the Board from seven members to six members. | 2026-02-20 | Streamlines board operations and reflects the new composition after resignations and appointments. |
| Independent Director Compliance | Appointment of Charles C. Jeong and Mi Jeong Lee as independent directors to comply with Nasdaq Listing Rule 5605 requirements for independent directors, audit committee, and compensation committee. | 2026-02-20 | Ensures the company meets critical Nasdaq governance standards, mitigating delisting risk and enhancing board oversight. |
| Committee Appointments | Charles C. Jeong appointed Chair of the Compensation Committee and Mi Jeong Lee appointed to the Audit Committee. | 2026-02-20 | Strengthens the independence and functionality of key board committees, crucial for sound corporate governance. |
Related Party Transactions
- Charles C. Jeong, a newly appointed director, previously entered into a Securities Subscription Agreement on October 20, 2025, to purchase 1,192,661 shares of common stock for $6,500,000 at $5.45 per share.
Stakeholder Impact
- Shareholders: The remediation of Nasdaq non-compliance helps maintain the company's listing, preserving liquidity and investor access to the stock. The initial non-compliance could have caused concern, but the swift resolution is reassuring.
Next Steps
- The company must continue to evidence compliance with Nasdaq listing rules.
- The company's next annual stockholders meeting will be a key event for director elections.
- Nasdaq will monitor the company's compliance during the cure period.
Key Dates
| Date | Description |
|---|---|
| 2025-10-20 | Company entered into a Securities Subscription Agreement with Charles C. Jeong for 1,192,661 shares of common stock at $5.45 per share. |
| 2026-02-19 | Reborn Coffee, Inc. received a notification letter from Nasdaq Listing Qualifications Staff regarding non-compliance with listing rules. |
| 2026-02-20 | Board of Directors resolved to decrease board size from seven to six members and appointed Charles C. Jeong and Mi Jeong Lee as new independent directors. |
| 2026-02-23 | Date of signing of the Current Report on Form 8-K. |
| 2026-08-12 | Latest date for the company to evidence compliance if its next annual stockholders meeting is held before this date. |
| 2027-02-13 | Latest date for the company to regain compliance if its next annual stockholders meeting is held after August 12, 2026. |
Recommendation
holdWhile the initial Nasdaq non-compliance is a significant concern, the company's immediate and effective remediation by appointing independent directors and restructuring the board mitigates the immediate delisting risk. The situation highlights governance vulnerabilities but the swift corrective action suggests management's commitment to maintaining listing standards. Investors should hold to observe sustained compliance and further operational performance, as the underlying business health is not directly addressed by this governance update.
Keywords
Reborn Coffee, REBN, Nasdaq compliance, Board of Directors, corporate governance, independent directors, audit committee, compensation committee, SEC filing, Form 8-K, delisting risk, management changes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.